Day: March 23, 2026

us corporate news

Ashford Hospitality Trust 2025 Annual Report: Regional Hotel Performance & Financial Highlights

Minichart

March 23, 2026

Ashford Hospitality Trust Inc. 2025 Annual Report: Key Inves...

Continue Reading 0

us corporate news

SUNation Energy, Inc. 2025 Annual Report: Company Overview, Risk Factors, Financials, and Nasdaq Listing (SUNE) 45

Minichart

March 23, 2026

SUNation Energy, Inc. 2025 Annual Report – Key Investor Insi...

Continue Reading 0

us corporate news

FinWise Bancorp 2025 Annual Report: Key Risks, Strategic Programs, and Forward-Looking Statements 51 52 55 56 57

Minichart

March 23, 2026

FinWise Bancorp 2025 Annual Report: Key Insights and Shareho...

Continue Reading 0

us corporate news

Cartesian Growth Corporation III 2025 Annual Report: Business Strategy, Risk Factors, and Acquisition Criteria Overview

Minichart

March 23, 2026

Detailed Investor Update: Cartesian Growth Corporation III A...

Continue Reading 0

us corporate news

Aterian, Inc. 2025 Annual Report: Business Overview, Strategic Alternatives, and Key Risks for E-Commerce Brands

Minichart

March 23, 2026

Aterian, Inc. 2025 Annual Report – Investor Summary Ater...

Continue Reading 0

us corporate news

Core Laboratories Inc. 2025 Annual Report – Business Overview, Strategy, Operations, and Climate Initiatives

Minichart

March 23, 2026

Core Laboratories Inc. 2025 Annual Report: Key Developments ...

Continue Reading 0

us corporate news

Idaho Strategic Resources, Inc. 2025 Annual Report: Gold & Rare Earth Mining Operations, Risks, and Property Overview

Minichart

March 23, 2026

Idaho Strategic Resources, Inc. Annual Report Highlights & K...

Continue Reading 0

us corporate news

Avalo Therapeutics 2025 Annual Report: Clinical Pipeline, Regulatory Risks, and Competitive Landscape

Minichart

March 23, 2026

Avalo Therapeutics, Inc. (AVTX) 2025 Annual Report: Key Insi...

Continue Reading 0

us corporate news

MicuRx Pharmaceuticals: Advancing Novel ADC Therapy MICVO for Difficult-to-Treat Head and Neck Cancer – Pipeline, Strategy, and Risks Overview

Minichart

March 23, 2026

Pyxis Oncology 2025 Annual Report: Key Highlights for Invest...

Continue Reading 0

us corporate news

Arbutus Biopharma 2025 Annual Report: Clinical Pipeline, Patent Litigation, and Strategic Outlook

Minichart

March 23, 2026

Arbutus Biopharma Corp 2025 Annual Report: Key Investor High...

Continue Reading 0